Leadership


The Team is led by Dr. Philip Low, Founder, Chairman, and CEO of NeuroVigil. 

Adjunct Professor, Stanford School of Medicine
Research Affiliate, MIT Media Lab
Winner, KAVLI Brain and Mind Innovative Research award
Winner, Draper Fisher Jurvetson Venture Challenge
Winner, UCSD Entrepreneurship Competition
Winner, CONNECT Most Innovative New Product
Top Young Innovator, Worldwide, MIT-TR35
Top 10 Most Innovative Companies in Health Care, Worldwide
Winner, Jacobs-Rady Pioneer Award for Global Innovation and Entrepreneurship

Philip Low is Chairman and Chief Executive Officer of NeuroVigil, the award-winning wireless neurodiagnostics company headquartered in San Diego. At the University of Chicago, he invented novel neurosurgical techniques. At Harvard Medical School, he showed in 9 weeks that a collagen inhibitor could successfully neutralize the growth of fibroid tumors – he was 19 years old at the time. At the Salk Institute, he invented the SPEARS algorithm and authored a one-page PhD thesis, a solution to a longstanding problem in brainwave analysis, which was unanimously approved by a committee including four members of the National Academy of Sciences and two past Presidents of the Society for Neuroscience. The degree was officially granted by UCSD, which had tried to flunk him out of the PhD program five years prior. Dr. Low holds dual appointments at the Stanford School of Medicine and the MIT Media Lab, as well as an extraordinary ability recognition in the field of brain signal detection from the United States Government. He was named President of the 1st International Congress on Alzheimer’s Disease and Advanced Neurotechnologies, held in Monaco in February 2010. His work has been featured in technical and popular articles including CNN, The Economist, Forbes and The New York Times. To bring his innovations to the market, Dr. Low founded NeuroVigil when he was still in graduate school and enlisted four Nobel Laureates and three Fortune 100 company founders. Under Dr. Low’s leadership, NeuroVigil won the 2008 UCSD Entrepreneurship Competition, the annual DFJ Venture Challenge, the 2010 CONNECT Most Innovative New Product Award for iBrain™, a wireless iPod for the brain, used by some of the world’s top pharmaceutical companies with outpatient drug evaluations, and was listed by Fast Company as one of the Top 10 Most Innovative Companies in Health Care, along with GE and the Cleveland Clinic. NeuroVigil successfully went to market in 2009. For his innovative contributions to Biomedicine as well as for his business leadership, Dr. Low has been recognized in 2010 by the MIT Technology Review as one of the 35 top innovators under 35 worldwide. Past recipients include the founders of Linux, Netscape, Paypal, Google and Facebook. On May 1st 2011, NeuroVigil successfully completed one of the largest seed valuation financings to-date. The same year, Dr. Low became the first recipient of the inaugural Jacobs-Rady Pioneer Award for Global Innovation and Entrepreneurship, awarded once every five years, irrespectively of age, gender or geographical location, to an exceptional scientist and chief executive for combined leadership in technology and business.


Legal Counsel

NeuroVigil is represented by Mayer Brown, LLP.

Mr. Ian Feinberg, Partner at Mayer Brown, LLP. Mr. Feinberg has extensive experience in handling trials, binding arbitrations, and trial preparation of, and counseling (including litigation avoidance) regarding, patent, copyright, trade secret, trademark, licensing, unfair competition and antitrust matters, particularly in the software and semiconductor industries. Mr. Feinberg obtained his J.D. at Stanford Law School in 1979, where he made Law Review. He graduated Phi Beta Kappa from Stanford with a B.A. in Economics, with distinction in 1976. He was admitted to the California Bar in 1979 and served on the United States District Courts for Northern, Southern, Central and Eastern Districts of California, the United States District Court of Arizona and United States Court of Appeals for the Ninth Circuit. Mr. Feinberg is NeuroVigil's Lead Attorney.